News
TKPHF
32.60
NaN%
--
Weekly Report: what happened at TKPHF last week (0720-0724)?
Weekly Report · 7h ago
Takeda dengue vaccine receives marketing authorization from India DCGI
TipRanks · 6d ago
Weekly Report: what happened at TKPHF last week (0713-0717)?
Weekly Report · 07/20 09:58
Weekly Report: what happened at TKPHF last week (0706-0710)?
Weekly Report · 07/13 10:00
Takeda Pharmaceutical to invest $30M in Indonesia's new national plasma donation network
Seeking Alpha · 07/13 08:06
Takeda, the Indoensian Government announce collaboration
TipRanks · 07/12 23:15
Takeda Finalizes Share Issuance for Global Employee Incentive Plan
TipRanks · 07/08 06:54
Takeda Pharmaceutical Co (TKPHF) Receives a Buy from Bernstein
TipRanks · 07/07 11:26
Weekly Report: what happened at TKPHF last week (0629-0703)?
Weekly Report · 07/06 10:02
Weekly Report: what happened at TKPHF last week (0622-0626)?
Weekly Report · 06/29 09:59
Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
Seeking Alpha · 06/26 13:22
Takeda finalizes 18-month transition: Julie Kim officially appointed President & CEO
Seeking Alpha · 06/24 07:51
Takeda Names Julie Kim CEO and Strengthens Board for Next Growth Phase
TipRanks · 06/24 07:23
Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib
TipRanks · 06/23 12:40
Weekly Report: what happened at TKPHF last week (0615-0619)?
Weekly Report · 06/22 10:06
Takeda presents additional results from oveporexton studies at SLEEP 2026
TipRanks · 06/15 16:05
Weekly Report: what happened at TKPHF last week (0608-0612)?
Weekly Report · 06/15 10:06
Takeda Pharmaceutical: The Downside Was Forecastable
Seeking Alpha · 06/11 19:27
Takeda announces results for Phase 3 study of TAK-279
TipRanks · 06/11 11:12
FDA accepts Takeda’s application for intravenous Entyvio
TipRanks · 06/09 20:37
More
Webull provides a variety of real-time TKPHF stock news. You can receive the latest news about Takeda Pharmaceutical Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TKPHF
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.